Desert King® is a leading manufacturer dedicated to discovering scientific solutions through natural components. With a focus on saponin-based products, the company has established itself as a reliable supplier in the pharmaceutical industry. Notably, Desert King® is recognised for its QS-21, which has set the standard for human vaccine adjuvants. As the proven supplier of Quillaja saponins utilised in five globally approved vaccines, including those for COVID-19, malaria, RSV, and shingles, Desert King® possesses the unique capability to deliver large, ready-to-ship GMP+ volumes. Their extensive reserves are well-positioned to meet the increasing demand, facilitating the production of millions of additional vaccine doses.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Biologics

Desert King® continues to be at the forefront of innovative solutions in the pharmaceutical sector. For more information, please visit desertking.com.